C4 Therapeutics (CCCC) Tax Provisions (2019 - 2024)
C4 Therapeutics' (CCCC) quarterly Tax Provisions came in at $131000.0 in Q4 2024, down 53.21% year-on-year from $280000.0 in Q1 2024, and down 53.21% quarter-over-quarter from $280000.0 in Q4 2023.
C4 Therapeutics (CCCC) Tax Provisions (2019 - 2024) Analysis & Trends
C4 Therapeutics' Tax Provisions history runs 4 years deep, the most recent figure standing at $131000.0 for Q4 2024.
- On a quarterly basis, Tax Provisions fell 53.21% year-over-year to $131000.0 in Q4 2024; TTM through Dec 2024 was $131000.0, a 89.79% decrease from a year earlier, with the FY2025 full-year figure at $121000.0, down 7.63% from the prior year.
- Tax Provisions slipped to $131000.0 in Q4 2024 per CCCC's latest filing, from $280000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $1.0 million in Q3 2023 and bottomed at -$168000.0 in Q2 2020.
- The 3-year median for Tax Provisions is -$124000.0 (2020), against an average of $112571.4.
- Biggest YoY gain for Tax Provisions was 29.17% in 2020; the steepest drop was 125.69% in 2020.
- Year by year, Tax Provisions stood at -$124000.0 in 2020, then surged by 325.81% to $280000.0 in 2023, then slumped by 53.21% to $131000.0 in 2024.
- Per Business Quant, the three latest CCCC Tax Provisions figures stand at $131000.0 (Q4 2024), $280000.0 (Q4 2023), and $1.0 million (Q3 2023).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | C4 Therapeutics | 460.17 Mn | 224.50 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 131,000.00 |
| Dec 31, 2023 | 280,000.00 |
| Sep 30, 2023 | 1.00 Mn |
| Dec 31, 2020 | -124,000.00 |
| Sep 30, 2020 | -167,000.00 |
| Jun 30, 2020 | -168,000.00 |
| Mar 31, 2020 | -167,000.00 |
| Dec 31, 2019 | -96,000.00 |
| Sep 30, 2019 | 650,000.00 |